Abstract
The menopause transition is a natural phase of women’s lives.
Generally between the ages of 42 to 55, many women experience perimenopausal symptoms, which are described as a group of symptoms related to autonomic nervous dysfunction in women. These symptoms are a consequence of pituitary hyper-function and ovarian function decline, with consequent fluctuation and/or decline in oestrogen levels. There are understood to be 34 known symptoms related to PMS, which include hot flushes, night sweats, depression and anxiety. Literature presents evidence of women’s lived experience of shame relating to menopause symptoms, and pervasive, negative discourses regarding menopause and ageing. Loss of oestrogen activity may negatively impact mental wellbeing, including the experience of ageing.
Generally between the ages of 42 to 55, many women experience perimenopausal symptoms, which are described as a group of symptoms related to autonomic nervous dysfunction in women. These symptoms are a consequence of pituitary hyper-function and ovarian function decline, with consequent fluctuation and/or decline in oestrogen levels. There are understood to be 34 known symptoms related to PMS, which include hot flushes, night sweats, depression and anxiety. Literature presents evidence of women’s lived experience of shame relating to menopause symptoms, and pervasive, negative discourses regarding menopause and ageing. Loss of oestrogen activity may negatively impact mental wellbeing, including the experience of ageing.
Original language | English |
---|---|
Pages | 31-33 |
Number of pages | 3 |
Volume | 9 |
No. | 9 |
Specialist publication | Aesthetics Journal |
Publication status | Published - 1 Aug 2022 |
Keywords
- Menopause
- Depression
- Botulinum Toxin
- Neurotoxin